Development and validation of a deep learning signature for predicting lymphovascular invasion and survival outcomes in clinical stage IA lung adenocarcinoma: A multicenter retrospective cohort study

CONCLUSION: The effectiveness of the DL signature in the diagnosis of LVI and prognosis prediction in patients with clinical stage IA lung adenocarcinoma was demonstrated. These findings suggest the potential of the model in clinical decision-making.PMID:38324961 | PMC:PMC10851213 | DOI:10.1016/j.tranon.2024.101894

Source: Translational Oncology - February 7, 2024 Category: Cancer & Oncology Authors: Kunfeng Liu Xiaofeng Lin Xiaojuan Chen Biyun Chen Sheng Li Kunwei Li Huai Chen Li Li Source Type: research